4
Changes in Ownership
Avalyn Pharma Inc. Filed Acc 0001193125-26-201860
Options or other derivatives
- Director acquired 26,978 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lavelle Erin Director | 2026-04-30 | Grant or award · Stock Option (Right to Buy) | +26,978 | 26,978 | D | ||
Loading xslF345X06/ownership.xml…